Innovations in Healthcare Management That Foster Enhanced Patient Safety and Quality of Care
DOI:
https://doi.org/10.56294/hl2023292Keywords:
Healthcare management, Patient safety, Artificial Intelligence, Telemedicine, Robotics, Internet of Things (IoT)Abstract
Making patients safer and improving the quality of the treatment received in hospitals depends on improvements in the way healthcare is run. These fresh concepts improve clinical outcomes and patient care by means of sophisticated technology, process optimisation, and data-driven tactics, thereby strengthening healthcare systems. This is so that healthcare systems, handling more patients and more complex clinical scenarios, may be Among the most significant developments are using artificial intelligence (AI) and machine learning (ML) in decision-making. Accurate diagnosis, tailored treatment strategies, and proactive patient monitoring are therefore made feasible. By use of predictive analytics and artificial intelligence systems, one may identify potential hazards, therefore reducing errors and ensuring appropriate timing of action. Particularly in rural and underdeveloped regions, telemedicine has also altered a lot regarding the management of healthcare. By allowing physicians to interact with patients from far-off, telemedicine increases access to healthcare services and monitors patients. Electronic health records (EHR) have also streamlined handling patient information. this is in order that clinicians may additionally make higher decisions as they offer reliable, real-time access to clinical know-how, take a look at findings, and therapy guidelines. Another extensive development is the use of robotic systems in affected person care and healing procedures. These techniques significantly boom sufferers' healing periods via making treatments pretty specific, consequently lowering mistakes. While still making sure sufferers get the great treatment feasible, using robots for therapy and affected person tracking allows healthcare specialists to simplify their tasks. The usage of internet of things (IoT) devices, actual-time tracking systems additionally reveal patients' health constantly and notify healthcare body of workers at once need to something occur that might be elaborate. This reduces the dangers associated with responding too slowly and quickens remedy. These traits also are facilitating the cooperation of people from all backgrounds, which improves coordination of patient care, communication among healthcare specialists, and an extra all-encompassing method to affected person protection.
References
1. Khetan, S.K.; Collins, T.J. Human pharmaceuticals in the aquatic environment: A challenge to Green Chemistry. Chem. Rev. 2007, 107, 2319–2364.
2. Montes-Grajales, D.; Fennix-Agudelo, M.; Miranda, W. Occurrence of personal care products as emerging chemicals of concern in water resources: A review. Sci. Total Environ. 2017, 595, 601–614.
3. Mudgal, S.; De Toni, A.; Lockwood, S.; Salès, K.; Backhaus, T.; Sorensen, B.H. Study on the Environmental Risks of Medicinal Products; BIO Intelegence Service: Neuilly Sur Seine, France, 2011.
4. Ch.V.L.L.Kusuma Kumari. (2015). Performance Appraisal: Dimensions and Determinants. International Journal on Research and Development - A Management Review, 4(3), 27 - 32.
5. Kompalli Sasi Kumar. (2015). Short Run and Long Run Performance of Indian Initial Public Offerings (IPOs) during 2007-2012. International Journal on Research and Development - A Management Review, 4(3), 33 - 41.
6. Chander, V.; Sharma, B.; Negi, V.; Aswal, R.S.; Singh, P.; Singh, R.; Dobhal, R. Pharmaceutical Compounds in Drinking Water. J. Xenobiot. 2016, 6, 5774.
7. Zuccato, E.; Castiglioni, S.; Fanelli, R.; Reitano, G.; Bagnati, R.; Chiabrando, C.; Pomati, F.; Rossetti, C.; Calamari, D. Pharmaceuticals in the environment in Italy: Causes, occurrence, effects and control. Environ. Sci. Pollut. Res. Int. 2006, 13, 15–21.
8. Desbiolles, F.; Malleret, L.; Tiliacos, C.; Wong-Wah-Chung, P.; Laffont-Schwob, I. Occurrence and ecotoxicological assessment of pharmaceuticals: Is there a risk for the Mediterranean aquatic environment? Sci. Total Environ. 2018, 639, 1334–1348.
9. Li, W.C. Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil. Environ. Pollut. 2014, 187, 193–201.
10. Wu, D.; Zhou, Y.; Lu, G.; Hu, K.; Yao, J.; Shen, X.; Wei, L. The Occurrence and Risks of Selected Emerging Pollutants in Drinking Water Source Areas in Henan, China. Int. J. Environ. Res. Public Health 2019, 16, 4109.
11. Balakrishna, K.; Rath, A.; Praveenkumarreddy, Y.; Guruge, K.S.; Subedi, B. A review of the occurrence of pharmaceuticals and personal care products in Indian water bodies. Ecotoxicol. Environ. Saf. 2017, 137, 113–120.
12. McEneff, G.; Schmidt, W.; Quinn, B. Pharmaceuticals in the Aquatic Environment: A Short Summary of Current Knowledge and the Potential Impacts on Aquatic Biota and Humans. EPA Res. Rep. 2015, 142, 52.
13. Sabino, J.A.; de Sá Salomão, A.L.; de Oliveira Muniz Cunha, P.M.; Coutinho, R.; Marques, M. Occurrence of organic micropollutants in an urbanized sub-basin and ecological risk assessment. Ecotoxicology 2021, 30, 130–141.
14. Quadra, G.R.; Oliveira de Souza, H.; Costa, R.D.; Fernandez, M.A. Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country. Environ. Sci. Pollut. Res. Int. 2017, 24, 1200–1218.
15. Pacheco Ferreira, A. Environmental Investigation of Psychiatric Pharmaceuticals: Guandu River, Rio De Janeiro State, Southeast Brazil. J. Chem. Health Risks 2018, 4.
Published
Issue
Section
License
Copyright (c) 2023 Alicia B. Medizza , Wilma A. Simoes , Virginia Jewtuchowicz , María Laura Garzon (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.